Long-Term Efficacy and Safety of Enzalutamide Monotherapy in Elderly Patients with Metastatic Castration-Resistant Prostate Cancer: A Case Report.

Autor: Pokrivcak T; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Navratil J; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Poprach A; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Stanik M; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic., Kiss I; Masaryk Memorial Cancer Institute, Brno, Czech Republic.; Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Publikováno v: Case reports in oncology [Case Rep Oncol] 2024 Apr 04; Vol. 17 (1), pp. 537-542. Date of Electronic Publication: 2024 Apr 04 (Print Publication: 2024).

Impact of Immunotherapy on Real-World Survival Outcomes in Metastatic Renal Cell Carcinoma.

Autor: Poprach A; Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic., Kiss I; Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic., Stanik M; Department of Urologic Oncology, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic., Barusova T; Institute of Biostatistics and Analyses Brno, Brno, Czech Republic., Pospisilova L; Institute of Biostatistics and Analyses Brno, Brno, Czech Republic., Fiala O; Department of Oncology and Radiotherapy, Faculty of Medicine and University Hospital in Pilsen, Charles University, Pilsen, Czech Republic.; Faculty of Medicine in Pilsen, Biomedical Centre, Charles University, Pilsen, Czech Republic., Kopecky J; University Hospital in Hradec Králové, Hradec Králové, Czech Republic., Richter I; Department of Oncology, Liberec Regional Hospital, Liberec, Czech Republic., Melichar B; Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic., Studentova H; Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic., Lakomy R; Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic., Holanek M; Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic., Rozsypalova A; Department of Oncology, First Faculty of Medicine, Charles University and Thomayer University Hospital, Prague, Czech Republic., Zemanková A; Department of Oncology, Palacky University Medical School and Teaching Hospital, Olomouc, Czech Republic., Svoboda M; Department of Comprehensive Cancer Care and Faculty of Medicine, Masaryk Memorial Cancer Institute and Masaryk University, Brno, Czech Republic., Buchler T; Department of Oncology, Second Faculty of Medicine, Charles University and Motol University Hospital, V Uvalu 84, 150 06, Prague, Czech Republic. tomas.buchler@fnmotol.cz.

Publikováno v: Targeted oncology [Target Oncol] 2023 Nov; Vol. 18 (6), pp. 893-903. Date of Electronic Publication: 2023 Nov 13.

Combination of Urinary MiR-501 and MiR-335 With Current Clinical Diagnostic Parameters as Potential Predictive Factors of Prostate Biopsy Outcome.

Autor: Juracek J; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Madrzyk M; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Trachtova K; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Ruckova M; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Bohosova J; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Barth DA; Research Unit of Non-Coding RNAs and Genome Editing in Cancer, Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria., Pichler M; Research Unit of Non-Coding RNAs and Genome Editing in Cancer, Division of Clinical Oncology, Department of Medicine, Comprehensive Cancer Center Graz, Medical University of Graz, Graz, Austria., Stanik M; Department of Urologic Oncology, Clinic of Surgical Oncology, Masaryk Memorial Cancer Institute, Brno, Czech Republic; stanik@mou.cz., Slaby O; Central European Institute of Technology, Masaryk University, Brno, Czech Republic; ondrej.slaby@ceitec.muni.cz.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Publikováno v: Cancer genomics & proteomics [Cancer Genomics Proteomics] 2023 May-Jun; Vol. 20 (3), pp. 308-316.

Decreased expression levels of PIWIL1, PIWIL2, and PIWIL4 are associated with worse survival in renal cell carcinoma patients

Autor: Iliev R, Stanik M, Fedorko M, Poprach A, Vychytilova-Faltejskova P, Slaba K, Svoboda M, Fabian P, Pacik D, Dolezel J, Slaby O

Publikováno v: OncoTargets and Therapy, Vol 2016, Iss Issue 1, Pp 217-222 (2016)

Robert Iliev,1,2 Michal Stanik,3 Michal Fedorko,4 Alexandr Poprach,1 Petra Vychytilova-Faltejskova,1,2 Katerina Slaba,2 Marek Svoboda,1 Pavel Fabian,5 Dalibor Pacik,1 Jan Dolezel,2 Ondrej Slaby3,4 1Department of Comprehensive Cancer Care, Masaryk Mem

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doajarticles::084391dbc118040cb24b60c1511ae6a2
https://www.dovepress.com/decreased-expression-levels-of-piwil1-piwil2-and-piwil4-are-associated-peer-reviewed-article-OTT

LncRNA PVT1 is increased in renal cell carcinoma and affects viability and migration in vitro.

Autor: Bohosova J; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Kasik M; Department of Urology, The University Hospital Brno, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Kubickova A; Department of Pharmacology, Faculty of Medicine, Masaryk University, Brno, Czech Republic., Trachtova K; Central European Institute of Technology, Masaryk University, Brno, Czech Republic., Stanik M; Department of Urologic Oncology, Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Brno, Czech Republic., Poprach A; Department of Urologic Oncology, Department of Comprehensive Cancer Care, Faculty of Medicine, Masaryk Memorial Cancer Institute, Masaryk University, Brno, Czech Republic., Slaby O; Central European Institute of Technology, Masaryk University, Brno, Czech Republic.; Department of Biology, Faculty of Medicine, Masaryk University, Brno, Czech Republic.

Publikováno v: Journal of clinical laboratory analysis [J Clin Lab Anal] 2022 Jun; Vol. 36 (6), pp. e24442. Date of Electronic Publication: 2022 Apr 20.